Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 3 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.

Recs

0
Player Avatar OklaBoston (68.73) Submitted: 3/2/2013 11:07:29 PM : Underperform Start Price: $88.46 EW Score: +26.65

P/Book over 6 and most other numbers little if any better.

Charts rather toppy also. That may not be as meaningful as I once believed, but is still worth something. And it harmonizes with my view of the fundamentals, which is not the case as often as I wish it were.

Featured Broker Partners


Advertisement